VTR
Ventas, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$89.42
+2.73%Oct 28, 2026, 07:11 UTC
Ventas, Inc. reported third-quarter 2026 revenue of $1,831,791,000, net income of $65,380,000, and diluted EPS of $0.13; normalized FFO per share was $0.99, up 10% year over year.
Source:Sep 25, 2026, 20:15 UTC
Ventas, Inc. announced that it will release its third quarter 2026 earnings after market close on October 27, 2026, with a conference call on October 28, 2026.
Source:Sep 15, 2026, 20:18 UTC
Ventas, Inc. appointed Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, effective October 5, 2026.
Sep 14, 2026, 20:32 UTC
Ventas, Inc. declared a quarterly dividend of $0.52 per common share, payable in cash on October 15, 2026 to stockholders of record as of September 30, 2026.
Source:Aug 23, 2026, 08:32 UTC
Callan Family Office LLC disclosed a new minority stake in Ventas, Inc., purchasing 25,940 shares valued at approximately $2,303,000 during the quarter.
Source:Jul 29, 2026, 20:10 UTC
Ventas, Inc. reported its financial results for the second quarter ended June 30, 2026.
Jun 22, 2026, 21:56 UTC
Ventas, Inc. named Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, effective August 2026.
Jun 15, 2026, 00:00 UTC
Carey S. Roberts resigned as Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc., effective June 26, 2026.